This finding is supported by the longitudinal increase in quantitative IFN-γ responses in TB contacts prior to diagnosis with active TB [12], [13], as well as declining IFN-γ responses seen in TB patients in low burden settings undergoing treatment [14]–[16]. The gene discussed is IFNG; the disease is tuberculosis.